Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 415.80
+12.40 (3.07%)
Jun 18, 2026, 4:08 PM HKT
HKG:6990 Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, HKG:6990 stock has a consensus rating of "Strong Buy" and an average price target of $547.64. The average 1-year stock price forecast is 31.71% higher than the current stock price, while the lowest is $500.70 (+20.42%) and the highest is $624.96 (+50.30%).
Price Target: $547.64 (+31.71%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for HKG:6990 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 15 | 16 | 16 | 15 | 15 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 20 | 19 | 19 | 19 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $550.00 | Buy | Maintains | $550.00 | +32.28% | Jun 4, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $529.97 → $544.61 | Buy | Maintains | $529.97 → $544.61 | +30.98% | Jun 3, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $625.00 | Buy | Maintains | $625.00 | +50.31% | Jun 1, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains $544.00 | Buy | Maintains | $544.00 | +30.83% | May 22, 2026 |
Unknown Analyst Nomura No rating | Nomura | Buy Maintains $544.42 | Buy | Maintains | $544.42 | +30.93% | May 22, 2026 |
Financial Forecast
Revenue This Year
2.73B
from 2.06B
Increased by 32.61%
Revenue Next Year
4.56B
from 2.73B
Increased by 67.28%
EPS This Year
-0.35
from -1.04
EPS Next Year
3.34
from -0.35
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.7B | ||
| Avg | 2.7B | ||
| Low | 2.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 81.9% | ||
| Avg | 32.6% | ||
| Low | -1.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.74 | ||
| Avg | -0.35 | ||
| Low | -0.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |